Effects of melatonin on disease improvement and serum levels of pro-inflammatory cytokines in patients with non-atypical endometrial hyperplasia

References

• Endometrial Hyperplasia. Seminars in Diagnostic Pathology. In Mills, A. M., Longacre, T. A., Eds. Elsevier: 2010.
   Google Scholar
• Ring, K. L.; Mills, A. M.; Modesitt, S. C. Endometrial Hyperplasia. Obstet. Gynecol. 2022, 140(6), 1061–1075. DOI: 10.1097/AOG.0000000000004989.
   PubMed Web of Science ®Google Scholar
• Vahedpour, Z.; Boroumand, H.; Tabatabaee Anaraki, S.; Tabasi, Z.; Motedayyen, H.; Akbari, H.; Raygan, F.; Ostadmohammadi, V. Effects of Isoflavone Supplementation on the Response to Medroxyprogesterone in Premenopausal Women with Nonatypical Endometrial Hyperplasia: A Randomized, Double-Blind, Placebo-Controlled Trial. Int. J. Clin. Pract. 2022, 2022, 1–6. DOI: 10.1155/2022/1263544.
   Web of Science ®Google Scholar
• Montgomery, B. E.; Daum, G. S.; Dunton, C. J. Endometrial Hyperplasia: A Review. Obstet. Gynecol. Sur. 2004, 59(5), 368–378. DOI: 10.1097/00006254-200405000-00025.
   PubMed Web of Science ®Google Scholar
• Palmer, J. E.; Perunovic, B.; Tidy, J. A. Endometrial Hyperplasia. Obstet. Gynaecol. 2008, 10(4), 211–216. DOI: 10.1576/toag.10.4.211.27436.
   Google Scholar
• Kubyshkin, A.; Aliev, L.; Fomochkina, I.; Kovalenko, Y. P.; Litvinova, S.; Filonenko, T.; Lomakin, N. V.; Kubyshkin, V. A.; Karapetian, O. V. Endometrial Hyperplasia-Related Inflammation: Its Role in the Development and Progression of Endometrial Hyperplasia. Inflamm. Res. 2016, 65(10), 785–794. DOI: 10.1007/s00011-016-0960-z.
   PubMed Web of Science ®Google Scholar
• Garcia, F.; Chen, H.-L.; Yang, Y.; Pace, J.; Hu, X.-L.; Hunt, J. Tumor Necrosis Factor-α mRNA and Protein in Endometrial Tumors: Analysis by in situ Hybridization and Immunocytochemistry. Hum. Pathol. 1994, 25(12), 1324–1331. DOI: 10.1016/0046-8177(94)90093-0.
   PubMed Web of Science ®Google Scholar
• Orostica, L.; Astorga, I.; Plaza-Parrochia, F.; Vera, C.; Garcia, V.; Carvajal, R.; Gabler, F; Romero, C.; Vega, M. Proinflammatory Environment and Role of TNF-α in Endometrial Function of Obese Women Having Polycystic Ovarian Syndrome. Int. J. Obes. 2016, 40(11), 1715–1722. DOI: 10.1038/ijo.2016.154.
   Web of Science ®Google Scholar
• Vaskivuo, T. E.; Stenbäck, F.; Tapanainen, J. S. Apoptosis and Apoptosis‐Related Factors Bcl‐2, Bax, Tumor Necrosis Factor‐α, and NF‐Κb in Human Endometrial Hyperplasia and Carcinoma. Cancer. 2002, 95(7), 1463–1471. DOI: 10.1002/cncr.10876.
   PubMed Web of Science ®Google Scholar
• Mahdi, H.; Rose, P. G.; Abdul-Karim, F. W.; Monk, B. J.; Ni, Y. The Role of Proinflammatory Immune (IFN-Gamma) Gene Signature in Predicting Prognosis and Response to Chemotherapy in Uterine Carcinoma. JCO 2019, 37(15_suppl), e14209–e14209. DOI: 10.1200/JCO.2019.37.15_suppl.e14209.
   Web of Science ®Google Scholar
• Bellelis, P.; Frediani Barbeiro, D.; Gueuvoghlanian-Silva, B. Y.; Kalil, J.; Abrão, M. S.; Podgaec, S. Interleukin-15 and Interleukin-7 Are the Major Cytokines to Maintain Endometriosis. Gynecologic. Obstetric. Investigation. 2019, 84(5), 435–444. DOI: 10.1159/000496607.
   PubMed Web of Science ®Google Scholar
• Gmyrek, G. B.; Sieradzka, U.; Goluda, M.; Gabryś, M.; Sozański, R.; Jerzak, M.; Zbyryt, L; Chrobak, A; Chełmońska-Soyta, A. Flow Cytometric Evaluation of Intracellular Cytokine Synthesis in Peripheral Mononuclear Cells of Women with Endometriosis. Immunol. Invest. 2008, 37(1), 43–61. DOI: 10.1080/08820130701554962.
   PubMed Web of Science ®Google Scholar
• Chandra, V.; Kim, J. J.; Benbrook, D. M.; Dwivedi, A.; Rai, R. Therapeutic Options for Management of Endometrial Hyperplasia. J. Gynecol. Oncol. 2016, 27(1). DOI: 10.3802/jgo.2016.27.e8.
   PubMed Web of Science ®Google Scholar
• Altun, A.; Ugur‐Altun, B. Melatonin: Therapeutic and Clinical Utilization. Int. J. Clin. Pract. 2007, 61(5), 835–845. DOI: 10.1111/j.1742-1241.2006.01191.x.
   PubMed Web of Science ®Google Scholar
• Abdel-Hamid, H. A.; Zenhom, N. M.; Toni, N. D. Melatonin Reduced Endometrial Hyperplasia Induced by Estradiol in Female Albino Rats. Gpb 2019, 38(1), 63–71. DOI: 10.4149/gpb_2018035.
   Google Scholar
• Ciortea, R.; Costin, N.; Braicu, I.; Haragâş, D.; Hudacsko, A.; Bondor, C.; Mihu, D.; Mihaela Mihu, C. Effect of Melatonin on Intra-Abdominal Fat in Correlation with Endometrial Proliferation in Ovariectomized Rats. Anticancer Res. 2011, 31(8), 2637–2643.
   PubMed Web of Science ®Google Scholar
• Lissoni, P.; Tancini, G.; Barni, S.; Paolorossi, F.; Ardizzoia, A.; Conti, A.; Maestroni, G. Treatment of Cancer Chemotherapy-Induced Toxicity with the Pineal Hormone Melatonin. Support Care Cancer 1997, 5(2), 126–129. DOI: 10.1007/BF01262569.
   PubMed Web of Science ®Google Scholar
• Shafabakhsh, R.; Reiter, R. J.; Mirzaei, H.; Teymoordash, S. N.; Asemi, Z. Melatonin: A New Inhibitor Agent for Cervical Cancer Treatment. J. Cell. Physiol. 2019, 234(12), 21670–21682. DOI: 10.1002/jcp.28865.
   PubMed Web of Science ®Google Scholar
• Garcia, L. S. Melatonin and Its Effects: The Truth Behind This Popular Supplement.
   Google Scholar
• Ciortea, R.; Costin, N.; Groza, D. M.; Mocan, R.; Şuşman, S. Effect of Melatonin on Endometrial Proliferation in Ovariectomized Female Rats. Gynaecology 2010, 6(19), 1–19.
   Google Scholar
• Li, Y.; Li, S.; Zhou, Y.; Meng, X.; Zhang, J.-J.; Xu, D.-P.; Bin Li, H. Melatonin for the Prevention and Treatment of Cancer. Oncotarget 2017, 8(24), 39896. DOI: 10.18632/oncotarget.16379.
   PubMedGoogle Scholar
• Sivas, M. C.; Tapisiz, O. L.; Ayik, R. T.; Kahraman, D.; Altinbas, S. K.; Tekin, O. M. Effects of Melatonin on Uterine Hypertrophy/Hyperplasia: A Preliminary Experimental Rat Study. Heliyon. 2020, 6(10), e05142. DOI: 10.1016/j.heliyon.2020.e05142.
   PubMed Web of Science ®Google Scholar
• Armstrong, A. J.; Hurd, W. W.; Elguero, S.; Barker, N. M.; Zanotti, K. M. Diagnosis and management of endometrial hyperplasia. J. Minim. Invasive. Gynecol. 2012, 19(5), 562–571.
   PubMed Web of Science ®Google Scholar
• Organization, W. H. International Agency for Research on Cancer. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man. 1994.
   Google Scholar
• Wiltbank, M.; Souza, A.; Giordano, J.; Nascimento, A.; Vasconcelos, J.; Pereira, M.; Fricke, P. M.; Surjus, R. S.; Zinsly, F. C. S.; Carvalho, P. D.; et al. Positive and Negative Effects of Progesterone During Timed AI Protocols in Lactating Dairy Cattle. Anim. Reproduction (AR) 2018, 9(3), 231–241.
   Google Scholar
• Tavartkiladze, A. A.; Tavartkiladze, L. A. Concentration of Blood Serum Melatonin in Patients with Simple and Complex Endometrial Hyperplasia. Ann. Oncol. 2014, 25(67). DOI: 10.1093/annonc/mdu435.95.
   Google Scholar
• Dznelashvili, N.; Kasradze, D.; Tavartkiladze, A.; Mariamidze, A.; Dzhinchveladze, D. Expression of Epidermal Growth Factor Receptor and Plasmatic Level of Melatonin in Simple and Complex Endometrial Hyperplasia. Georgian Med. News 2013, (223), 91–95.
   PubMedGoogle Scholar
• Sundström-Poromaa, I.; Comasco, E.; Sumner, R.; Luders, E. Progesterone–Friend or Foe? Front. Neuroendocrinol. 2020, 59, 100856. DOI: 10.1016/j.yfrne.2020.100856.
   PubMed Web of Science ®Google Scholar
• Xie, Z.; Chen, F.; Li, W. A.; Geng, X.; Li, C.; Meng, X.; Feng, Y.; Liu, W.; Yu, F. A Review of Sleep Disorders and Melatonin. Neurological. Res. 2017, 39(6), 559–565. DOI: 10.1080/01616412.2017.1315864.
   PubMed Web of Science ®Google Scholar
• Hardeland, R. Melatonin and Inflammation—Story of a Double‐Edged Blade. J. Pineal Res. 2018, 65(4), e12525. DOI: 10.1111/jpi.12525.
   PubMed Web of Science ®Google Scholar
• Lysenko, O. Benign Endometrial Lesions in Premenopausal Women: Three-Dimensional Power Doppler Sonography and Cytokines Content. Prog. In Health Sci. 2013, 3(2), 11.
   Google Scholar
• Zhdanov, A.; Sukhikh, G.; Davydova, M.; Slukina, T.; Chernukha, G.; Samoilova, T.; Smetnik, V. P. Correlations in the Cytokine System in Endometrial Hyperplasia. Bull. Exp. Biol. And Med. 2003, 136(3), 270–272. DOI: 10.1023/B:BEBM.0000008980.25653.1b.
   PubMed Web of Science ®Google Scholar
• Srinivasan, V.; Maestroni, G. J.; Cardinali, D. P.; Esquifino, A.; Perumal, S. P.; Miller, S. C. Melatonin, Immune Function and Aging. Immun. Ageing. 2005, 2(1), 1–10. DOI: 10.1186/1742-4933-2-17.
   PubMedGoogle Scholar
• Morrey, K. M.; McLachlan, J. A.; Serkin, C. D.; Bakouche, O. Activation of Human Monocytes by the Pineal Hormone Melatonin. J. Immunol. 1994, 153(6), 2671–2680. DOI: 10.4049/jimmunol.153.6.2671.
   PubMed Web of Science ®Google Scholar
• Jamilian, M.; Foroozanfard, F.; Mirhosseini, N.; Kavossian, E.; Aghadavod, E.; Bahmani, F.; Ostadmohammadi, V.; Kia, M.; Eftekhar, T.; Ayati, E., et al. Effects of Melatonin Supplementation on Hormonal, Inflammatory, Genetic, and Oxidative Stress Parameters in Women with Polycystic Ovary Syndrome. Front. Endocrinol. 2019, 10, 273. DOI: 10.3389/fendo.2019.00273.
   PubMed Web of Science ®Google Scholar
• Akbari, M.; Ostadmohammadi, V.; Tabrizi, R.; Lankarani, K. B.; Heydari, S. T.; Amirani, E.; Reiter, R. J.; Asemi, Z. The Effects of Melatonin Supplementation on Inflammatory Markers Among Patients with Metabolic Syndrome or Related Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Inflammopharmacol. 2018, 26(4), 899–907. DOI: 10.1007/s10787-018-0508-7.
   PubMed Web of Science ®Google Scholar
• Antomarchi, J.; Ambrosetti, D.; Cohen, C.; Delotte, J.; Chevallier, A.; Karimdjee-Soilihi, B.; Ngo-Mai, M.; Schmid-Alliana, A.; Schmid-Antomarchi, H. Immunosuppressive Tumor Microenvironment Status and Histological Grading of Endometrial Carcinoma. Cancer. Microenvironment. 2019, 12(2–3), 169–179. DOI: 10.1007/s12307-019-00225-1.
   PubMed Web of Science ®Google Scholar
• Mollo, A.; Stile, A.; Alviggi, C.; Granata, M.; De Placido, G.; Perrella, A.; d’Antonio, A.; Cicinelli, E. Endometrial Polyps in Infertile Patients: Do High Concentrations of Interferon-Gamma Play a Role? Fertil. Steril. 2011, 96(5), 1209–1212. DOI: 10.1016/j.fertnstert.2011.08.001.
   PubMed Web of Science ®Google Scholar
• Sukhikh, G.; Zhdanov, A.; Davydova, M.; Slukina, T.; Chernukha, G.; Samoilova, T.; Smetnik, V. P. Disorders in Cytokine Gene Expression in Endometrial Hyperplasia and Effect of Hormone Therapy. Bull. Exp. Biol. Med 2005, 139(2), 235–237. DOI: 10.1007/s10517-005-0257-7.
   PubMed Web of Science ®Google Scholar
• Garcia-Maurino, S.; Gonzalez-Haba, M. G.; Calvo, J. R.; Rafii-El-Idrissi, M.; Sanchez-Margalet, V.; Goberna, R.; Guerrero, J. M. Melatonin Enhances IL-2, IL-6, and IFN-Gamma Production by Human Circulating CD4+ Cells: A Possible Nuclear Receptor-Mediated Mechanism Involving T Helper Type 1 Lymphocytes and Monocytes. J. Immunol. 1997, 159(2), 574–581. DOI: 10.4049/jimmunol.159.2.574.
   PubMed Web of Science ®Google Scholar
• Maestroni, G. J. The Immunotherapeutic Potential of Melatonin. Expert Opinion on Investigational Drugs. Expert Opin. Invest. Drugs. 2001, 10(3), 467–476. DOI: 10.1517/13543784.10.3.467.
   PubMed Web of Science ®Google Scholar
• Arzt, E. S.; Fernández-Castelo, S.; Finocchiaro, L. M.; Criscuolo, M. E.; Díaz, A.; Finkielman, S.; Nahmod, V. E. Immunomodulation by Indoleamines: Serotonin and Melatonin Action on DNA and Interferon-γ Synthesis by Human Peripheral Blood Mononuclear Cells. J. Clin. Immunol. 1988, 8(6), 513–520. DOI: 10.1007/BF00916958.
   PubMed Web of Science ®Google Scholar